The 200 mg tablets of rifaximin have also been used in the treatment of Crohn's disease with dosages of 600 mg/day for 16 weeks as described by Shafran, I., Am. J. Gastroenterol., 2003, 98 (Suppl.) S-250. Thus, there is a need in-the-art for a rifaximin pharmaceutical ...
ITMI20050345A12006-09-08 Other References: Rossi, C. et al., “NMR Investigation of a New Semisynthetic Bioactive Compound,” Bulletin of Magnetic Resonance, 1996, vol. 18, No. 1-2, pp. 87-90. Viscomi, G. et al., “Crystal Forms of Rifaximin and Their Effect on Pharmaceutical Prope...